Literature DB >> 10685069

Pathogenesis of ANCA-associated systemic vasculitis.

L Harper1, C O Savage.   

Abstract

The aetiology of primary systemic vasculitides remains unknown. Recent advances have been made in the understanding of relevant mechanisms of inflammation, particularly the role of the endothelium and interactions with inflammatory mediators and immune effector cells. In Wegener's granulomatosis and microscopic polyangiitis the evidence suggests an autoimmune inflammatory process, characterized by an early lesion involving neutrophils and endothelial cells as both targets and active participants; priming of neutrophils and endothelial cells allows ANCA to activate neutrophils with damage localized to the endothelium. In the absence of immune complex deposition, the role of the ANCA is particularly intriguing. Endothelial cell damage and activation produces pro-inflammatory mediators with influx monocytes and T cells intensifying damage. Increased understanding of the pathogenesis of systemic vasculitis is likely to provide the basis for the use of more selective immunomodulatory therapies in the future. Copyright 2000 John Wiley & Sons, Ltd.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10685069     DOI: 10.1002/(SICI)1096-9896(200002)190:3<349::AID-PATH524>3.0.CO;2-A

Source DB:  PubMed          Journal:  J Pathol        ISSN: 0022-3417            Impact factor:   7.996


  35 in total

Review 1.  Polyarteritis nodosa and microscopic polyangiitis: etiologic and diagnostic considerations.

Authors:  Laura B Hughes; S Louis Bridges
Journal:  Curr Rheumatol Rep       Date:  2002-02       Impact factor: 4.592

Review 2.  Wegener's granulomatosis and the Churg-Strauss syndrome.

Authors:  J L Faul; W G Kuschner
Journal:  Clin Rev Allergy Immunol       Date:  2001-08       Impact factor: 8.667

Review 3.  Clinical management and treatment of vasculitis.

Authors:  D Jayne
Journal:  Springer Semin Immunopathol       Date:  2001

4.  Plasma levels of soluble endothelial cell protein C receptor in patients with Wegener's granulomatosis.

Authors:  M M Boomsma; D J Stearns-Kurosawa; C A Stegeman; E Raschi; P L Meroni; S Kurosawa; J W Cohen Tervaert
Journal:  Clin Exp Immunol       Date:  2002-04       Impact factor: 4.330

5.  Wegener's granulomatosis presenting with gross hematuria due to prostatitis.

Authors:  A Brunner; A Tzankov; T Akkad; K Lhotta; G Bartsch; G Mikuz
Journal:  Virchows Arch       Date:  2003-10-24       Impact factor: 4.064

6.  Mechanisms of ANCA-mediated leukocyte-endothelial cell interactions in vivo.

Authors:  Sarah L Nolan; Neena Kalia; Gerard B Nash; Dia Kamel; Peter Heeringa; Caroline O S Savage
Journal:  J Am Soc Nephrol       Date:  2008-02-27       Impact factor: 10.121

7.  Anti-Nuclear Cytoplasmic Antibody-Associated Vasculitis: A Probable Adverse Effect of Sofosbuvir Treatment in Chronic Hepatitis C Patients.

Authors:  Youssef K Ahmad; Salwa Tawfeek; Mohamed Sharaf-Eldin; Hassan E Elbatea; Abdelrahman Kobtan; Ferial El-Kalla; Rehab Badawi; Sherief Abd-Elsalam
Journal:  Hosp Pharm       Date:  2017-04

8.  Hypogalactosylation of serum IgG in patients with ANCA-associated systemic vasculitis.

Authors:  M Holland; K Takada; T Okumoto; N Takahashi; K Kato; D Adu; A Ben-Smith; L Harper; C O S Savage; R Jefferis
Journal:  Clin Exp Immunol       Date:  2002-07       Impact factor: 4.330

9.  Serum sFAS levels are elevated in ANCA-positive vasculitis compared with other autoimmune diseases.

Authors:  Marta Christensson; Erna Pettersson; Kjell Eneslätt; Birger Christensson; Johan Bratt; Solbritt Rantapää-Dahlqvist; Karl-Gösta Sundqvist
Journal:  J Clin Immunol       Date:  2002-07       Impact factor: 8.317

Review 10.  Small vessel vasculitis.

Authors:  Paul Brogan; Despina Eleftheriou; Michael Dillon
Journal:  Pediatr Nephrol       Date:  2009-11-03       Impact factor: 3.714

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.